Aviva Tobin‐Hess - Concepedia

Author

Aviva Tobin‐Hess

Also Known As

A Tobin-Hess, Aviva Tobin-Hess, Aviva Tobin‐Hess

Publications

244

Citations

H-Index

Concepts

All Affiliations

Aviva Tobin‐Hess is an author at Icahn School of Medicine at Mount Sinai specializing in breast cancer, medicine, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	112
2	Cell Biology	2	2	74
3	Immunology	2	2	102
4	Diabetes	1	1	10
5	Pathology	1	1	38

Aviva Tobin‐Hess

Publications

234

Citations

H-Index

Page 1

	Year	Citations
Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor Emily J. Gallagher, Nyosha Alikhani, Aviva Tobin‐Hess, Diabetes Breast OncologyImmunologyInsulin Receptor PhosphorylationIgf-i ReceptorInsulin Signaling	2013	64
Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer Rosalyn D. Ferguson, Emily J. Gallagher, Dara Cohen, Endocrine Related Cancer	2013	50
Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression Zara Zelenko, Emily J. Gallagher, Aviva Tobin‐Hess, Oncogene Mammary Gland DevelopmentMedicineVimentin ExpressionImmunologyPathology	2016	38
The effect of dipeptidyl peptidase‐IV inhibition on bone in a mouse model of type 2 diabetes Emily J. Gallagher, Hui Sun, C Kornhauser, Diabetes/Metabolism Research and Reviews	2013	36
Trends in Fidelis Lead Survival Jim W. Cheung, Aviva Tobin‐Hess, Apoor Patel, Circulation Arrhythmia and Electrophysiology	2012	20
OP449 inhibits breast cancer growth without adverse metabolic effects Gadi Shlomai, Zara Zelenko, Irini Markella Antoniou, Endocrine Related Cancer	2017	16
Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes Emily J. Gallagher, Zara Zelenko, Aviva Tobin‐Hess, Diabetologia Breast Cancer GrowthBreast OncologyGrowth HormoneInsulin ManagementDiabetes	2016	10

Page 1